# HSBC MSCI China UCITS ETF Accum USD (HCHS) **Source:** https://fundology.uk/fund/hchs · ISIN IE0007P4PBU1 · Data: TradingView (LSE closes and returns, delayed), issuer documents and holdings (HSBC), ONS CPIH, FCA FIRDS ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 01/10/2026, HCHS (HSBC MSCI China UCITS ETF Accum USD, ISIN IE0007P4PBU1) closed at £6.09 on the London Stock Exchange. Its ongoing charge is 0.28% a year (about £28 on £10,000). Over the three years to 01/10/2026 its total return was +8.7%, or −2.0% after UK CPIH inflation. ## Summary HSBC MSCI China UCITS ETF Accum USD is an exchange-traded fund (ETF) from HSBC, launched in 2022. It tracks the MSCI China. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.28% a year — about £28 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£6.09** (01/10/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | HCHS | | ISIN | IE0007P4PBU1 | | Category | Emerging markets | | Type | ETF | | Provider | HSBC | | Tracks | MSCI China | | Income | Accumulating | | Ongoing charge | 0.28% a year (£28 per £10,000) | | Fund size | £82.3m | | Launched | 2022 | | Domicile | Ireland | ## Past returns (periods to 01/10/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | -17.40% | -20.00% | income reinvested | | 3 years | +8.65% | -1.96% | income reinvested | Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published. ## Calendar-year returns Calendar-year returns of HSBC MSCI China UCITS ETF Accum USD in pounds (price, with income reinvested in the fund): 2023 −16.5%, 2024 +21.8%, 2025 +21.7%; 2026 to 01/10/2026 −11.5%. Returns of HSBC MSCI China UCITS ETF Accum USD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: −15.8%; to 30/09/2025: +30.7%; to 30/09/2024: +9.8%; to 30/09/2023: −5.4%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2023 | -16.5% | -19.8% | Price | | 2024 | +21.8% | +17.6% | Price | | 2025 | +21.7% | +17.6% | Price | | 2026 to 01/10/2026 | -11.5% | -13.9% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 16.23% | -20.95% | | 3 years | 23.45% | -20.95% | ## Largest fall Volatility of HSBC MSCI China UCITS ETF Accum USD in pounds, annualised from weekly returns to 01/10/2026: 16.2% over 1 year, 23.4% over 3 years. Largest fall in the price of HSBC MSCI China UCITS ETF Accum USD since July 2022, in pounds: −34.5% from 27/01/2023 to 02/02/2024. The lowest 12-month return of HSBC MSCI China UCITS ETF Accum USD in pounds (price, with income reinvested in the fund) since July 2022 was −32.4% (12 months to 02/02/2024); the highest was +55.8% (12 months to 12/09/2025). On 01/10/2026 the price of HSBC MSCI China UCITS ETF Accum USD was 18.7% below its highest weekly close since July 2022 (03/10/2025), in pounds. ## Charges compared with similar funds Ongoing charge of HSBC MSCI China UCITS ETF Accum USD 0.28% a year, as of 02/10/2026: 84 of the 141 other emerging-market share funds charge more, 2 the same and 55 less (share classes counted once). ## Funds tracking the same index 7 funds track MSCI China, this one included and share classes counted once; their ongoing charges range from 0.22% to 0.65% a year (01/10/2026). | Fund | Ongoing charge | 1 year | 3 years | 5 years | |---|---|---|---|---| | Franklin MSCI China Paris Aligned Climate UCITS ETF | 0.22% | -21.9% | +3.4% | — | | HSBC MSCI China UCITS ETF | 0.28% | -17.4% | +19.7% | -9.9% | | HSBC MSCI China UCITS ETF Accum USD (this fund) | 0.28% | -17.4% | +8.7% | — | | iShares MSCI China UCITS ETF AccumUSD | 0.28% | -17.1% | +21.6% | -9.0% | | Multi Units LU -Amundi MSCI China ETF Acc- Capitalisation | 0.29% | -16.5% | +21.6% | -8.8% | | Xtrackers MSCI China UCITS ETF 1D Distribution | 0.30% | -17.4% | +8.6% | — | | Xtrackers MSCI CHINA UCITS ETF Capitalisation 1C | 0.65% | -17.7% | +18.4% | -11.6% | Returns are the data vendor’s, in pounds, income reinvested unless marked "(price)". ## Charges & eligibility - Ongoing charges figure (OCF): **0.28%** per year - ISA eligible: yes - SIPP eligible: yes ## What it holds As of 02/06/2025, HCHS holds 401 positions, according to the holdings HSBC publishes. The largest is Capital Cash Ctrl at 7.51% of the fund; the ten largest make up 26.7%. ### Top holdings Largest positions (as of 02/06/2025), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | Capital Cash Ctrl | — | 7.51% | | 2 | Kweichow Moutai · Class A | [600519](https://fundology.uk/stock/600519) | 5.03% | | 3 | Contemporary Amperex Technology · Class A | [300750](https://fundology.uk/stock/300750) | 2.89% | | 4 | China Merchants Bank · Class A | [600036](https://fundology.uk/stock/600036) | 2.36% | | 5 | China Yangtze Power · Class A | [600900](https://fundology.uk/stock/600900) | 1.94% | | 6 | Byd · Class A | [002594](https://fundology.uk/stock/002594) | 1.68% | | 7 | Ping An Insurance (Group) Co. of China · Class A | — | 1.51% | | 8 | Wuliangye Yibin · Class A | [000858](https://fundology.uk/stock/000858) | 1.29% | | 9 | Agricultural Bank of China · Class A | [601288](https://fundology.uk/stock/601288) | 1.24% | | 10 | Industrial Bank · Class A | [601166](https://fundology.uk/stock/601166) | 1.24% | Source: HSBC, holdings as published, as of 02/06/2025. ## Where it invests Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed. ### By country Added up from the holdings HSBC publishes, as of 02/06/2025. | Country | Weight | |---|---| | China | 99.3% | | Singapore | 0.6% | | Not classified | 10.6% | All 401 holdings: https://fundology.uk/fund/hchs/holdings ## Questions people ask **What is the ongoing charge of HCHS?** The ongoing charge of HCHS is 0.28% a year — about £28 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of HSBC MSCI China UCITS ETF Accum USD 0.28% a year, as of 02/10/2026: 84 of the 141 other emerging-market share funds charge more, 2 the same and 55 less (share classes counted once). **What does HCHS track?** HCHS tracks the MSCI China. **Is HCHS accumulating or distributing?** HCHS is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of HCHS?** The ISIN of HCHS is IE0007P4PBU1. An ISIN identifies one exact share class of a fund; HCHS is its ticker on the London Stock Exchange. **What does HCHS hold?** As of 02/06/2025, HCHS holds 401 positions, according to the holdings HSBC publishes. The largest is Capital Cash Ctrl at 7.51% of the fund; the ten largest make up 26.7%. Its ten largest holdings are Capital Cash Ctrl (7.51%), Kweichow Moutai · Class A (5.03%), Contemporary Amperex Technology · Class A (2.89%), China Merchants Bank · Class A (2.36%), China Yangtze Power · Class A (1.94%), Byd · Class A (1.68%), Ping An Insurance (Group) Co. of China · Class A (1.51%), Wuliangye Yibin · Class A (1.29%), Agricultural Bank of China · Class A (1.24%) and Industrial Bank · Class A (1.24%). **What were HCHS’s returns in each of the last five years?** Calendar-year returns of HCHS in pounds (price, with income reinvested in the fund): 2023 −16.5%, 2024 +21.8%, 2025 +21.7%; 2026 to 01/10/2026 −11.5%. Past performance is not a guide to future returns. **How has HCHS done after inflation?** Over the three years to 01/10/2026 HCHS’s total return was +8.7%, or −2.0% after UK CPIH inflation. Past performance is not a guide to future returns. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.